Breast Cancer Medical Reference

Kisqali is a kinase inhibitor. Here’s how it treats early breast cancer.

Inluryio is an oral estrogen receptor antagonist. Here’s how it treats breast cancer.

Take a look at how you play a vital role in your ER-positive breast cancer journey and get tips on how to be your best advocate to get tested for ESR1 mutations.

Learn about common and serious side effects of treatment, how you can manage them, and how to get support.

Explore ER-positive metastatic breast cancer with ESR1 mutation treatments, get tips to manage side effects, and learn which questions to ask.

HR+/HER2- metastatic breast cancer treatment usually involves systemic therapies that can bring on a range of side effects. Learn which ones and what to do.

A clinical trial can get you access to cutting-edge treatment for HR+/HER2- mBC. Find out whether one may be right for you and how to join.

Long-term health concerns can begin during or soon after breast cancer treatment. They may require treatment independent of your cancer care.

There are many promising new ways to treat, diagnose, and manage breast cancer. Researchers carry out clinical trials to study these new methods.

Talking openly with your cancer care team can help you get the best treatment, manage side effects, and feel more in control.

A guide to personal risk factors, and the treatments and lifestyle changes that might lower the chance of your cancer returning.

WebMD explores precision treatments for breast cancer.

You have early breast cancer with lymph node involvement and you’re worried about recurrence. Learn what role lymph node involvement plays in treatment, prognosis, and recurrence risk.

These steps may lower your chances of breast cancer returning.

You’ve been diagnosed with HR+/HER2- breast cancer and want to understand what a survival rate is and how you’ll fare with your disease. Here's what you need to know.

Your breast cancer pathology report is packed with important information, but it can be a bit overwhelming if you’ve never seen one before. Here are some tips and tricks to breaking down your pathology report.

Breast cancer treatment side effects can affect your quality of life. Learn the most common signs of when you may want to consider changing your breast cancer treatments because of side effects.

Both lumpectomies and mastectomies can help treat breast cancer in people with hormone receptor-positive (HR+), HER2-negative breast cancer. But which one is right for you can depend on many factors.

Have you been diagnosed with breast cancer? What you need to know about getting a second opinion and why.

Are there foods you should avoid to keep breast cancer from coming back? Learn tips from experts.

You want the most effective treatment for your breast cancer. Learn how molecular diagnostics can guide your doctors toward a treatment that works best for your tumor.

Culturally competent health care is about your team understanding where you come from, your values, and how to tailor care plans accordingly. Learn how you can find and build a culturally competent breast cancer care team.

When treatment doesn’t kill all the cancerous cells in your breast, cancer can come back. When it shows up in the pleura, the lining of your lungs, doctors call this pleural metastasis.

Learn how your menopausal status may affect your breast cancer diagnosis, treatment, and symptoms, and how to get the help you need when you have hormone receptor-positive, HER2-negative breast cancer.

Are you questioning your breast cancer treatment plan? What to know if you are rethinking it.

Learn which therapies are newly approved for early-stage breast cancer, and which ones are coming down the research pipeline.

Worries about recurrence are normal during or after breast cancer treatment. Learn more about your recurrence risk and how the right treatment plan can help to lower it.

A guide to make sense of your breast cancer treatment journey, including how both standard and newer, emerging therapies fit in

Cómo el cáncer de mama y sus tratamientos aumentan tu riesgo de pérdida ósea, y qué puedes hacer para protegerte."

You are a vital part of your HR+/HER2- breast cancer health care team. Learn how to advocate for yourself in the doctor’s office and beyond.

Your treatment for HR+/HER2- breast cancer with mutations may cause side effects. Here’s how to manage them.

Your HR+/HER2- breast cancer genetic mutations can make a difference in which treatments your doctor recommends. Find out how to be an active part of that decision.

What options do you have for treatment when your HR+/HER2- breast cancer has genetic mutations? Find out the latest treatments for these cancers.

Your hormone receptor status, HER2 status, and genetic mutations all play a part in your breast cancer makeup and treatment options.

Datroway is an antibody drug conjugate. Here’s how it treats breast cancer.

After mastectomy, you can choose from saline breast implants or silicone gel implants. Learn the benefits and risks of each.

A pathology report is an important tool in diagnosing early breast cancer. Find out what’s in it and how the information guides your treatment.

A breast cancer second opinion can reassure you about your diagnosis and treatment or provide other options for care. Learn how to get a second opinion.

Get information on the symptoms of breast cancer from the experts at WebMD.

With so many breast cancer treatment options available now, it can be hard to choose what's right for you. Here's what you need to know.

Breast Cancer: Treatment by Stage

Kinase inhibitors can help you live longer with HR+ breast cancer. Find out what they do, when they’re used, and what side effects they can cause.

Biologics have changed the game when it comes to breast cancer treatment. But what are they and who can benefit?

Endocrine therapy will likely be part of your treatment plan if you have HR+ breast cancer. Find out about the different options.

Trodelvy is a targeted cancer therapy. Here’s how it treats breast cancer.

Kisqali is a kinase inhibitor. Here’s how it treats breast cancer.

Orserdu is a targeted hormone therapy. Here’s how it treats breast cancer

Verzenio is a kinase inhibitor. Here’s how it treats metastatic breast cancer.

Ibrance is an oral kinase inhibitor. Here’s how it treats breast cancer.